Q4 2025 Earnings Call March 11, 2026 10:00 AM EDTCompany ParticipantsWarren Kanders - Executive Chairman & CEOBrad ...

Exynos 2600 is not just another new chip from Samsung; it’s a seriously powerful mobile processor built using the advanced 2nm process node. Samsung has switched to an all-big-core CPU design to offer ...

Kodiak’s AI driver pulls three trailers with one tractor Kodiak introduced advanced capabilities that allow the Kodiak Driver to pull three trailers with one tractor, a first in the autonomous vehicle ...

Compare KnockoutStocks vs Seeking Alpha: features, AI tools, pricing, and stock research capabilities to find the best ...

Portfolio loss drivers -- Ted Goldthorpe cited "a portfolio company called CPFLEX" and CIO cited "HTC Hostway" as the largest ...

Google Workspace CLI adds cross-app command control with pre-built skills; setup needs Google Cloud APIs and an OAuth client in one project.

C4 Therapeutics delivered strong 4Q25 results, with revenue up 111.5% YoY and operating expenses tightly controlled. Click for my latest analysis of CCCC stock.

Compare KnockoutStocks vs Simply Wall St for 2026. Discover which platform offers superior AI tools, stock analysis, picks, and screeners for investors.

Amprius Technologies. Electrifying growth. Amprius' revenue rocketed 137% higher year over year to $25.2 million i ...

Net Underwriting Profit -- $13 million reported, yielding a combined ratio of 92.1% for the quarter. Net Income (Q4) -- $49.3 million, translating to $1.44 per diluted share. Innovations Segment -- ...

Q4 reported revenue of $157.9 million increased 2.8% and organic* revenue increased 10.0%Fourth quarter GAAP earnings of $0.21 per diluted share compared to $0.00 in the prior-year periodNon-GAAP earn ...

NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage biotechnology company developing transformative therapies for the treatment of cancer and rare ...